首页> 外国专利> MONOCLONAL ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF, USES THEREOF, HYBRIDOMA CELL LINE FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING A MONOCLONAL ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF, IN VITRO METHOD FOR THE DIAGNOSIS OF AN AMYLOID-ASSOCIATED DISEASE AND KIT THEREFOR

MONOCLONAL ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF, USES THEREOF, HYBRIDOMA CELL LINE FOR PRODUCTION THEREOF, PHARMACEUTICAL COMPOSITION COMPRISING A MONOCLONAL ANTIBODY OR AN ANTIGEN-BINDING FRAGMENT THEREOF, IN VITRO METHOD FOR THE DIAGNOSIS OF AN AMYLOID-ASSOCIATED DISEASE AND KIT THEREFOR

机译:以此为基础的单克隆抗体或抗原结合片段,用于生产其的杂交细胞系,包含其单克隆抗体或抗原结合片段的药物组合物,用于诊断的体外方法及诊断方法

摘要

The application describes a monoclonal antibody or antigen-binding fragments thereof that bind to AβpGlu(11)-peptides, hybridoma cell lines producing said antibody or fragments thereof, pharmaceutical compositions comprising the same. Furthermore, the application disclosed the uses of said monoclonal antibody and fragments thereof for the diagnosis of amyloidosis, in particular Alzheimer's disease, and related condition, and also for the treatment, prevention or delay of amyloidosis, as well as corresponding methods and kits used therein.
机译:本申请描述了与AβpGlu(11)-肽结合的单克隆抗体或其抗原结合片段,产生所述抗体的杂交瘤细胞系或其片段,包含该抗体的药物组合物。此外,该申请公开了所述单克隆抗体及其片段在淀粉样变性特别是阿尔茨海默氏病和相关病症的诊断中的用途,以及在淀粉样变性的治疗,预防或延缓中的用途,以及其中使用的相应方法和试剂盒。 。

著录项

  • 公开/公告号EA032054B1

    专利类型

  • 公开/公告日2019-04-30

    原文格式PDF

  • 申请/专利权人 PROBIODRUG AG;

    申请/专利号EA20130001029

  • 申请日2012-03-16

  • 分类号C07K16/18;G01N33/68;

  • 国家 EA

  • 入库时间 2022-08-21 12:02:27

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号